Your browser doesn't support javascript.
loading
Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells.
Miyamoto, Keisuke; Minegaki, Tetsuya; Hirano, Sayaka; Hayashi, Itsuka; Tsujimoto, Masayuki; Nishiguchi, Kohshi.
Afiliação
  • Miyamoto K; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Minegaki T; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan t-minegaki@mb.kyoto-phu.ac.jp.
  • Hirano S; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Hayashi I; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Tsujimoto M; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Nishiguchi K; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
Anticancer Res ; 40(2): 813-823, 2020 Feb.
Article em En | MEDLINE | ID: mdl-32014924

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Inibidores de Poli(ADP-Ribose) Polimerases / Proteína 1 de Ligação à Proteína Supressora de Tumor p53 / Carcinoma de Células Escamosas do Esôfago Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Inibidores de Poli(ADP-Ribose) Polimerases / Proteína 1 de Ligação à Proteína Supressora de Tumor p53 / Carcinoma de Células Escamosas do Esôfago Idioma: En Ano de publicação: 2020 Tipo de documento: Article